ERBB2 and neoplasm: HER2 category 3 significantly increased the trend hazard ratio for tumour recurrence in a model 1 multivariate analysis (P=0.048) but failed to significantly increase the trend hazard ratio for tumour recurrence in a model 2 multivariate analysis (P=0.093).